VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AIRS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AIRSAirSculpt Technologies, Inc.
$4.48$316M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

AIRS logoAirSculpt Technologies, Inc.(AIRS)Earnings, Financials & Key Ratios

AIRS•NASDAQ
$4.48
Price updated Jul 6, 2026
SectorHealthcareIndustryHealthcare FacilitiesSub-IndustryOutpatient clinics and surgery centers
AboutAirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.Show more
  • Revenue$152M-15.8%
  • EBITDA$8M-21.1%
  • Net Income-$12M-41.4%
  • EPS (Diluted)-0.19-35.7%
  • Gross Margin59.37%-1.7%
  • EBITDA Margin5.24%-6.3%
  • Operating Margin-3.18%-216.2%
  • Net Margin-7.68%-68.0%
  • ROE-13.97%-38.3%

AIRS Price & Volume

AirSculpt Technologies, Inc. (AIRS) stock price & volume — 10-year historical chart

Loading chart...

Persistent Revenue Contraction Strains Clinical Operating Model

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and Solvency Constraints

Key Thesis Takeaways

  • AirSculpt Technologies faces a challenging fundamental outlook characterized by sustained revenue contraction and an inability to achieve consistent operating leverage, as evidenced by a recent negative operating margin of -3.18%.
  • The company's reliance on high-cost patient acquisition in an elective, discretionary market appears to be pressuring profitability, while a precarious liquidity position with a current ratio of 0.75 limits operational flexibility.
  • Investors should monitor the company's ability to stabilize procedure volumes and address its $71.0 million debt load, as the current trajectory suggests significant risks to long-term solvency.

Verdict Logic

the company's inability to maintain positive operating margins, which reached -2.2% in 2026Q1, combined with a current ratio of 0.75, indicates substantial financial risk.

AIRS Growth Metrics

AirSculpt Technologies, Inc. (AIRS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years19.32%
3 Years-3.47%
TTM-11.78%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM34.51%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM39.53%

Return on Capital

10 Years2.03%
5 Years1.56%
3 Years0.47%
Last Year-2.84%

AIRS Recent Earnings

AirSculpt Technologies, Inc. (AIRS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 8, 2026
Metric
Actual
Est
EPS
$0.03-50.0%
$0.02
Rev
$39M+0.5%
$39M
Q2 2026
Apr 2, 2026
Metric
Actual
Est
EPS
$0.02+180.0%
$0.03
Rev
$33M-3.1%
$34M
Q4 2025
Nov 7, 2025
Metric
Actual
Est
EPS
$0.04-300.0%
$0.01
Rev
$35M+0.2%
$35M
Q3 2025
Aug 1, 2025
Metric
Actual
Est
EPS
$0.02+0.0%
$0.02
Rev
$44M+10.6%
$40M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 8, 2026
$0.03vs $0.02-50.0%
$39Mvs $39M+0.5%
Q2 2026Apr 2, 2026
$0.02vs $0.03+180.0%
$33Mvs $34M-3.1%
Q4 2025Nov 7, 2025
$0.04vs $0.01-300.0%
$35Mvs $35M+0.2%
Q3 2025Aug 1, 2025
$0.02vs $0.02+0.0%
$44Mvs $40M+10.6%
Based on last 12 quarters of dataView full earnings history →

Latest AIRS News

Recent stock market news and headlines for AirSculpt Technologies, Inc. (AIRS)

Business Wire·Jun 16, 2026
AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions

HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation. Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) ac.

Peers Comparison

Key metrics vs top competitors for AirSculpt Technologies, Inc. (AIRS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
AIRS logoAIRSAirSculpt Technologies, Inc.Current
$4.48$316.04M-23.58-15.82%-7.68%-13.97%—
SKIN logoSKINThe Beauty Health Company
$0.75$97.84M-4.72-10.02%-2.03%-9.41%—
INMD logoINMDInMode Ltd.
$14.60$925.04M10.21-6.16%23.27%13.28%—
SSKN logoSSKNSTRATA Skin Sciences, Inc.
$0.12$705.41K-0.09-8.54%-21.13%-360.33%—
ESTA logoESTAEstablishment Labs Holdings Inc.
$91.56$2.69B-53.2327.14%-19.05%-225.86%—
MDT logoMDTMedtronic plc
$83.06$106.64B22.278.43%13.2%9.78%—

Compare AIRS vs Peers

AirSculpt Technologies, Inc. (AIRS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SKIN

Most directly comparable listed peer for AIRS.

Scale Benchmark

vs ABT

Larger-name benchmark to compare AIRS against a more recognizable public peer.

Peer Set

Compare Top 5

vs SKIN, INMD, SSKN, ESTA

AIRS SEC Filings & Documents

AirSculpt Technologies, Inc. (AIRS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 14, 2026·SEC

Material company update

May 8, 2026·SEC

Material company update

Apr 2, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 31, 2026·SEC

FY 2025

Mar 14, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 8, 2026·SEC

FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 1, 2025·SEC

Get notified when AIRS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AIRS Frequently Asked Questions

AirSculpt Technologies, Inc. (AIRS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is AirSculpt Technologies, Inc.'s revenue?

AirSculpt Technologies, Inc. (AIRS) reported $151.8M in revenue for fiscal year 2025. This represents a 268% increase from $41.2M in 2019.

How fast is AirSculpt Technologies, Inc. growing?

AirSculpt Technologies, Inc. (AIRS) saw revenue decline by 15.8% over the past year.

Is AIRS profitable?

AirSculpt Technologies, Inc. (AIRS) reported a net loss of $11.2M for fiscal year 2025.

Dividend & Returns
What is AIRS's return on equity?

AirSculpt Technologies, Inc. (AIRS) has a return on equity (ROE) of -14.0%. Negative ROE indicates the company is unprofitable.

What is AirSculpt Technologies, Inc.'s free cash flow?

AirSculpt Technologies, Inc. (AIRS) generated $6.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in AIRS back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →